138 related articles for article (PubMed ID: 37530357)
21. SMARCB1/INI1/BAF47- deficient pleural malignant mesothelioma with rhabdoid features.
Kimura N; Hasegawa M; Hiroshima K
Pathol Int; 2018 Feb; 68(2):128-132. PubMed ID: 29316066
[TBL] [Abstract][Full Text] [Related]
22. Sarcomatoid renal cell carcinoma with rhabdoid features.
Al-Saidi NA; Akhtar M
Ann Saudi Med; 2013; 33(5):495-9. PubMed ID: 24188946
[TBL] [Abstract][Full Text] [Related]
23. Case report metastatic SMARCB1 (INI1)-deficient gastric undifferentiated carcinoma in pleural effusion: A case report and literature review.
Zhong J; Xie Y; Niu Z; Xie M; Zhou D
Cytopathology; 2024 Jan; 35(1):153-156. PubMed ID: 37706577
[TBL] [Abstract][Full Text] [Related]
24. INI1/SMARCB1-Deficient Carcinoma (Rhabdoid Tumor) of the Lacrimal Gland.
Srinivasan A; Tuluc M; Jordan AJ; Curry JM; Bilyk JR
Ophthalmic Plast Reconstr Surg; 2019; 35(2):e41-e43. PubMed ID: 30856630
[TBL] [Abstract][Full Text] [Related]
25. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison.
Pacheco MC; Dolan M; Bendel A
Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842
[TBL] [Abstract][Full Text] [Related]
26. A case of retroperitoneal tumor displaying epithelial differentiation, prominent myxoid stroma and loss of INI1/SMARCB1.
Rekhi B; Thomas A
Pathologica; 2021 Dec; 113(6):456-462. PubMed ID: 34974552
[TBL] [Abstract][Full Text] [Related]
27. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
[TBL] [Abstract][Full Text] [Related]
28. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
Ramalingam P; Croce S; McCluggage WG
Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
[TBL] [Abstract][Full Text] [Related]
29. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
[TBL] [Abstract][Full Text] [Related]
30. SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.
Ayyanar P; Mishra P; Preetam C; Adhya AK
Head Neck Pathol; 2021 Jun; 15(2):555-565. PubMed ID: 33141418
[TBL] [Abstract][Full Text] [Related]
31. SMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report.
Fujita K; Mizuguchi K; Mori T; Shimoda T; Sakano K; Shimaguchi C; Ito A; Yoshimura K; Sakaguchi M; Imi T; Ikeda H
Diagn Cytopathol; 2023 Oct; 51(10):E294-E300. PubMed ID: 37475580
[TBL] [Abstract][Full Text] [Related]
32. Gastric adenocarcinoma with rhabdoid morphology.
Shomori K; Sugamura K; Adachi K; Shiomi T; Nanba E; Ito H
Gastric Cancer; 2011 Aug; 14(3):290-4. PubMed ID: 21409519
[TBL] [Abstract][Full Text] [Related]
33. Loss of BRG1 (
Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
[TBL] [Abstract][Full Text] [Related]
34. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
35. Dedifferentiated liposarcoma composed predominantly of rhabdoid/epithelioid cells: a frequently misdiagnosed highly aggressive variant.
Agaimy A; Michal M; Hadravsky L; Michal M
Hum Pathol; 2018 Jul; 77():20-27. PubMed ID: 29307627
[TBL] [Abstract][Full Text] [Related]
36. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
[TBL] [Abstract][Full Text] [Related]
37. Secondary INI1-deficient rhabdoid tumors of the central nervous system: analysis of four cases and literature review.
Nobusawa S; Nakata S; Yoshida Y; Yamazaki T; Ueki K; Amano K; Yamamoto J; Miyahara M; Sugai T; Nakazato Y; Hirato J; Yokoo H
Virchows Arch; 2020 May; 476(5):763-772. PubMed ID: 31707588
[TBL] [Abstract][Full Text] [Related]
38. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
[TBL] [Abstract][Full Text] [Related]
39. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
[TBL] [Abstract][Full Text] [Related]
40. Deep intronic hotspot variant explaining rhabdoid tumor predisposition syndrome in two patients with atypical teratoid and rhabdoid tumor.
Tauziède-Espariat A; Masliah-Planchon J; Brugières L; Puget S; Dufour C; Schneider P; Laquerrière A; Frebourg T; Bodet D; Lechapt-Zalcman E; Pierron G; Delattre O; Varlet P; Bourdeaut F
Eur J Hum Genet; 2017 Oct; 25(10):1170-1172. PubMed ID: 28722703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
